Aktuell 18 déc 2023 Planzer und Galenica gründen Health Supply AG Planzer und Galenica gründen die Gemeinschaftsfirma Health Supply AG mit Standort in Villmergen. Sie soll den Transport von Medikamenten und ande...
News 18 déc 2023 Planzer and Galenica launch Health Supply AG Planzer and Galenica are founding the joint venture Health Supply AG in Villmergen in the canton of Aargau. The aim is to make the transport of m...
News 06 juil 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
News 18 mai 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
News 11 mai 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...
News 30 nov 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
Actualités 11 mai 2021 bNOVATE, spin-off de l’EPFL, prend son envol au niveau mondial après avoir levé CHF 5 millions Avec ses solutions connectées permettant de mesurer les bactéries dans l’eau en seulement 20 minutes, le spécialiste de la microbiologie industri...
News 09 fév 2021 Pharmaceutical and biotech expert ZETA opens a new subsidiary in the canton of Valais ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of...
Analysis 22 mar 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
News 20 fév 2023 Limula and CSEM collaborate to make cellular therapies more accessible To improve the accessibility of cellular therapies using automation, Limula has received support from the CSEM from the prototyping phase to the ...
Aktuell 30 nov 2021 Hemex erhält 7,1 Millionen Franken Hemex hat in einer Serie C-Finanzierungsrunde insgesamt 7,1 Millionen Franken eingeworben. Das Unternehmen für klinische Auftragsforschung und In...
Aktuell 10 nov 2021 Kollagenmembran von Geistlich Pharma erhält Zulassung in den USA Geistlich Nexo-Gide hat die Zulassung der amerikanischen Aufsichtsbehörde erhalten. Die von Geistlich Pharma entwickelte Kollagenmembran unterstü...
Analyse 22 mar 2021 Digitales B2B-Marketing in China Die digitale Landschaft in China ist einzigartig und in rasanter Entwicklung, ganz anders als in Europa. Um herauszufinden, wo Schweizer Unterneh...
News 10 nov 2021 Geistlich Pharma’s collagen membrane authorized for use in the USA The Geistlich Nexo-Gide has obtained clearance from the US Food and Drug Administration (FDA). The collagen membrane developed by Geistlich Pharm...
News 08 mar 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business
Actualités 06 juil 2022 Qarad, société du groupe QbD, s’installe en Suisse Le spécialiste belge du diagnostic in vitro, Qarad, est votre porte d'entrée en Europe pour les diagnostics in vitro et les dispositifs médicaux....